Medicine Products
Osteomesh Bioresorbable Implant for Craniofacial Surgery
Description:Osteomesh is a bioresorbable implant used in craniofacial surgery to repair various types of fractures, like the orbital floor fracture and to fill surgical defects. It has interconnected pores which allow rapid saturation with marrow, blood and nutrients, thus providing the patients own cells with chemical signals that are required for bone growth and remodeling. The mesh is malleable and can be...Company:Osteopore InternationalDescription:AMD Now is a forum presenting interactive education on Age- related Macular Degeneration (AMD), AMD diagnosis and treatments, VEGF, aseptic technique and supportive care for patients and caregivers....
Company:ASORN
SWISSBLADE Diamond Surgical Knives
Description:SWISSBLADE disposable surgical knives single-use blades deliver a consistent, sharp, clean cut due to the low friction coefficient achieved with Ziemers proprietary coating technology. SWISSBLADE diamond surgical knives feature top-of-the-line, reusable blades with the proven superior cutting capabilities based on the diamond expertise of Ziemer Group partner Meyco (Biel, Switzerland) an...Company:ZIEMER USA, Inc.
MAXWELL Optical Wavefront Aberrometer
Description:The MAXWELL Optical Wavefront Aberrometer is an innovative diagnostic instrument with a wide range of functions that permit eye care practitioners and researchers to effectively assess all of the wavefront aberrations present in a subjects eye. This remarkable device offers the widest wavefront diagnostic range and functions on more than 99% of subjects. Beyond its superior performance in wavefro...Company:ZIEMER USA, Inc.
ConstaVac CBCII Blood Conservation System
Description:The Stryker CBCII Blood Conservation System provides a safe, simple and economic disposable system for blood reinfusion....Company:Stryker InstrumentsDescription:The combination of these recommendations with the exceptional design and engineering expertise of the Sorin Group has resulted in numerous improvements, such as: Slim design, integrated IV poles and reservoir holder for hassle-free storage The system easily detaches from the cart with just a flick of the lever, making transportation of the unit convenient and manageable <li...
Company:Sorin Group USA, Inc.Description:Haemonetics invented surgical blood salvage nearly thirty years ago and has been an innovator in the field ever since. The Cell Saver autologous blood recovery systems are used in operating room procedures in which there is rapid bleeding or high-volume blood loss....
Company:Haemonetics
Osteoplug Bioresorbable Implant for Trephination Burr Holes
Description:Posteoplug is a bioresorbable implant that is used for covering trephination burr holes in neurosurgery. This proprietary, user-friendly design, shaped like a flattened button mushroom, allows a snap fit into burr holes and requires no fixation by screws, unlike titanium plates. It has superior mechanical strength and the scaffold architecture minimizes potential injuries to the exposed brain th...Company:Osteopore International
RestorePRIME Neurostimulation System
Description:RESTOREPRIME is the First and Only 16-Electrode Non-Rechargeable Neurostimulator. Medtronic combined the powerful technology of RESTORE with the convenience of a non-rechargeable neurostimulator to create the unrivaled RESTOREPRIME. The ultimate non-rechargeable device, RESTOREPRIME offers flexibility and coverage for managing patients with bilateral and complex pain with low to modera...Company:Medtronic Neurological and Spinal
Rapid Programmer 3.0 Neurostimulation Programming Platform
Description:The Rapid Programmer 3.0 is the smallest and lightest-weight clinician programming platform in the industry. It enables clinicians to quickly and efficiently test patients intraoperatively and to create programs for them postoperatively....Company:Advanced Neuromodulation Systems, Inc.
(Date:5/14/2008)...y 14 /PRNewswire-FirstCall/ -- Biotel Inc. (OTC Bu...d quarter ended March 31, 2008,with net earnings o... of,$2,699,000. This compares to net earnings of $...f $2,990,000 for the third quarter of last year. F...d net earnings of $475,000,or $0.17 per diluted s...
(Date:5/14/2008)...y to survive using chemoradiation, and new treatme...althDay News) -- Tonsil and tongue cancers linked ...to current chemotherapy and radiation treatments, ...actor called EGFR are the least responsive and mos...f Michigan Comprehensive Cancer Center researchers...
(Date:5/14/2008)...s work well, too, giving patients options , ...rgest study of its kind supports the use of a popu...ts a cocktail of two classes of drugs is a good al... as well, said study lead author Dr. Sharon Riddle...ty of Pittsburgh. , "It,s not like 10 years a...
(Date:5/14/2008)...ight add to traditional risk factors , ,... four offbeat biomarkers accurately predicted the ...dy of older Swedish men, researchers report. , ... that might one day lead to widespread medical use...ed risk factors such as high blood pressure and ch...
Breaking Medicine News(10 mins):Health News:Biotel Announces Profitable Third Quarter Ended March 31, 2008 2Health News:HPV Tied to Better Tongue, Tonsil Cancer Outcomes 2Health News:Study Supports Popular HIV Drug Regimen 2Health News:Study Supports Popular HIV Drug Regimen 3Health News:Biomarkers Predict Heart Deaths 2Health News:Biomarkers Predict Heart Deaths 3...al Alcoholism: Clinical and Experimental Research ...f smell. Researchers from the University Clinics o...olics and 30 healthy people who were matched for a...' Sticks", which are pen-like devices that dispens...
...mmatory condition of the bladder wall. It typicall...so affect men. Investigators are testing the bacte...ier studies was found to be effective in treating ...ions into the bladders of patients through a cathe...
...n a recent seminar organised by Guru Gobind Singh ...utation', spoke about the comapny's plan of forayi...r products would create stiff competition for the ...er cent market share. The company plans to market ...
...his colleagues are enthused by their finding of a ...ying into human cells. This blocker, in its initia...smission of HIV between monkeys. The new study has... that hobble viruses - could act as shields agains...
Other Medicine News:...r mini horizontal gel electrophoresis system is de...estriction fragments in agarose gels. This system ...hern or Northern blotting of high quality. Complet..., 2 x Gel Maker Stands, (4) 52 x 60 mm Trays, (2) ...
...ni-Chameleon has a centimeter ruler etched into th...ncludes apparatus, connecting cables, three 7x10 c... and three 14-well combs. The Chameleon can accomo...electrophoresis of a maximum of 120 samples with a...
...ystem™ consists of a Separation-Control unit...elopment Unit for gel staining. The optional Phast...mi-dry blotting unit. Electrophoresis is performed...mperatures accurately from 0 to +70 C. Multi-step ...
...A 2000 apparatus and ready-to-use gels are the key...cleic acids by submerged gel electrophoresis. We p...ffering full compatibility and optimal performance...0 and a unique staining tray, the system includes ...
Medicine Products:(Date:5/13/2008)... with XIENCE V in SPIRIT III Trial Experience Bett...ent Thrombosis than Patients ... /- Long-term data,presente...al, Abbott,s U.S.,pivotal trial studying the XIENC...demonstrated that XIENCE V continues to deliver cl...
(Date:5/12/2008)...SCO, Calif., May 12 /- Napo...unces that it presented a,poster in collaboration ...t,of a patient reported outcomes questionnaire foc...) aspects of chronic diarrhea in persons living wi...Pharmacoeconomics and,Outcomes Research (ISPOR) An...
(Date:5/12/2008).../- GeoVax Labs, Inc. (OTC,B...accine development,company, announced today that i...hase agreement with Fusion Capital Fund II, LLC, a...ny may sell up to $10 million of its common stock ...h period after the Securities and,Exchange Commiss...
(Date:5/12/2008)...May 12 /- Arbios Systems, I...t the Company has received,approval from the U.S. ...gational Device Exemption ("IDE") to begin the piv...rporeal (outside the body) liver assist,device for...ing from,chronic liver disease., "We are pleased ...
Breaking Medicine Technology:XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5Napo Presents at ISPOR Meeting in Toronto 2GeoVax Secures $10 Million Financing Commitment 2GeoVax Secures $10 Million Financing Commitment 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development 3001 1Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development 3001 2Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development 3001 3Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development 3001 4Ceremeds OSTENE 28R 29 Stops Bone Bleeding Without Added Risk of Surgical Infection New Study Finds 1316 1Ceremeds OSTENE 28R 29 Stops Bone Bleeding Without Added Risk of Surgical Infection New Study Finds 1316 2Ceremeds OSTENE 28R 29 Stops Bone Bleeding Without Added Risk of Surgical Infection New Study Finds 1316 3Pharmaxis Investor Conference Call 2999 1Material Technologies Holds First Electrochemical Fatigue Sensor Training for Private Inspection Firms 2114 1Material Technologies Holds First Electrochemical Fatigue Sensor Training for Private Inspection Firms 2114 2Material Technologies Holds First Electrochemical Fatigue Sensor Training for Private Inspection Firms 2114 3[0] XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years[0] Napo Presents at ISPOR Meeting in Toronto[0] GeoVax Secures $10 Million Financing Commitment[0] Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device
...- Arrowhead Research,Corporation (NASDAQ: ARWR) an...idiary Calando Pharmaceuticals, Inc. of a study,de...iRNA sequence,selected as the therapeutic componen... paper, entitled "Potent siRNA Inhibitors of Ribon...feration In vitro and In,vivo", was published in C...
...laque Formation, ANNAPOLIS, Md., April 03, 2007 /P...nse company specializing in the development,and co... chemical,and biological terrorism, announced toda...esterase (rBChE) research program were,recently pr...heimer,s and Parkinson,s Diseases in Salzburg, Aus...
Other Medicine Technology:Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6| Copyright © 2003-2007 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |